未登录 FDA and industry collaboration: Identifying opportunities to further reduce reliance on nonhuman primates for nonclinical safety evaluations Ackley, David; Birkebak, Joanne; Blumel, Jorg; Bourcier, Todd; de Zafra, Christina; Goodwin, Andrew; Halpern, Wendy; Herzyk, Danuta; Kronenberg, Sven; Mauthe, Robert; Shenton, Jacintha; Shuey, Dana; Wange, Ronald L. 分享 收藏
An organizational approach for the assessment of DNA adduct data in risk assessment: case studies for aflatoxin B1, tamoxifen and vinyl chloride 风险评估中评估DNA加合物数据的组织方法: 黄曲霉毒素B1,他莫昔芬和氯乙烯的案例研究 Pottenger, Lynn H.; Andrews, Larry S.; Bachman, Ammie N.; Boogaard, Peter J.; Cadet, Jean; Embry, Michelle R.; Farmer, Peter B.; Himmelstein, Matthew W.; Jarabek, Annie M.; Martin, Elizabeth A.; Mauthe, Robert J.; Persaud, Rudranath; Preston, R. Julian; Schoeny, Rita; Skare, Julie; Swenberg, James A.; Williams, Gary M.; Zeiger, Errol; Zhang, Fagen; Kim, James H. 分享 收藏
分享 收藏
Follow-up testing of rodent carcinogens not positive in the standard genotoxicity testing battery: IWGT workgroup report Kasper, Peter; Uno, Yoshifumi; Mauthe, Robert; Asano, Norihide; Douglas, George; Matthews, Edwin; Moore, Martha; Mueller, Lutz; Nakajima, Madoka; Singer, Tim; Speit, Guenter 分享 收藏
A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity Müller, L; Mauthe, RJ; Riley, CM; Andino, MM; De Antonis, D; Beels, C; DeGeorge, J; De Knaep, AGM; Ellison, D; Fagerland, JA; Frank, R; Fritschel, B; Galloway, S; Harpur, E; Humfrey, CDN; Jacks, AS; Jagota, N; Mackinnon, J; Mohan, G; Ness, DK; O'Donovan, MR; Smith, MD; Vudathala, G; Yotti, L 分享 收藏
Comparative biotransformation studies of MeIQx and PhIP in animal models and humans Garner, RC; Lightfoot, TJ; Cupid, BC; Russell, D; Coxhead, JM; Kutschera, W; Priller, A; Rom, W; Steier, P; Alexander, DJ; Leveson, SH; Dingley, KH; Mauthe, RJ; Turteltaub, KW 分享 收藏
分享 收藏
分享 收藏
分享 收藏